Cell And Gene Therapies Are Altering Patient Expectations, Says CGT Catapult CEO

Patients Will Expect Their Condition To Be Taken Away, Rather Than Treated

 
• By Chloe Kent
  
Headshot of Matthew Durdy
Matthew Durdy took over as CGT Catapult CEO as the COVID-19 pandemic began in early 2020 • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Leadership

More from In Vivo